In the last trading session, 1.63 million shares of the Compugen Ltd (NASDAQ:CGEN) were traded, and its beta was 2.96. Most recently the company’s share price was $2.15, and it changed around -$0.27 or -11.16% from the last close, which brings the market valuation of the company to $192.50M. CGEN currently trades at a discount to its 52-week high of $3.03, offering almost -40.93% off that amount. The share price’s 52-week low was $1.35, which indicates that the current value has risen by an impressive 37.21% since then. We note from Compugen Ltd’s average daily trading volume that its 10-day average is 0.67 million shares, with the 3-month average coming to 696.13K.
Compugen Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended CGEN as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight.
Compugen Ltd (NASDAQ:CGEN) trade information
Instantly CGEN has showed a red trend with a performance of -11.16% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.66 on recent trading dayincreased the stock’s daily price by 19.17%. The company’s shares are currently up 40.52% year-to-date, but still down -9.28% over the last five days. On the other hand, Compugen Ltd (NASDAQ:CGEN) is 31.10% up in the 30-day period. We can see from the shorts that 1.27 million shares have been sold at a short interest cover period of 6.42 day(s).
The consensus price target as assigned by Wall Street analysts is $4, which translates to bulls needing to increase their stock price by 46.25% from its current value. Analyst projections state that CGEN is forecast to be at a low of $4 and a high of $4.
Compugen Ltd (CGEN) estimates and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 12.14%. Compugen Ltd earnings are expected to increase by 66.67% in 2025, but the outlook is negative -3.82% per year for the next five years.
Compugen Ltd (NASDAQ:CGEN)’s Major holders
TAYLOR FRIGON CAPITAL MANAGEMENT LLC, with 1.4685% or 1.31 million shares worth $2.21 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
